SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

ZUCCATO, Cristina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.355
AS - Asia 4.753
EU - Europa 2.960
SA - Sud America 764
AF - Africa 124
OC - Oceania 25
AN - Antartide 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 15.983
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.181
SG - Singapore 1.760
CN - Cina 1.335
BR - Brasile 627
PL - Polonia 604
IT - Italia 537
VN - Vietnam 452
DE - Germania 451
UA - Ucraina 341
HK - Hong Kong 338
GB - Regno Unito 239
TR - Turchia 211
FI - Finlandia 171
FR - Francia 166
IN - India 122
JP - Giappone 116
SE - Svezia 116
RU - Federazione Russa 111
ID - Indonesia 89
CA - Canada 85
BD - Bangladesh 81
MX - Messico 66
AR - Argentina 53
NL - Olanda 53
ZA - Sudafrica 44
PK - Pakistan 33
ES - Italia 28
IQ - Iraq 27
BE - Belgio 21
VE - Venezuela 21
CO - Colombia 20
EC - Ecuador 20
MY - Malesia 20
AU - Australia 19
IR - Iran 19
CZ - Repubblica Ceca 18
EG - Egitto 18
LT - Lituania 18
UZ - Uzbekistan 17
AE - Emirati Arabi Uniti 16
PH - Filippine 15
SA - Arabia Saudita 15
AT - Austria 14
GR - Grecia 13
KE - Kenya 12
MA - Marocco 12
CH - Svizzera 10
IL - Israele 9
KR - Corea 9
TH - Thailandia 9
TN - Tunisia 9
CL - Cile 8
IE - Irlanda 7
JO - Giordania 7
KZ - Kazakistan 7
LV - Lettonia 7
AZ - Azerbaigian 6
CR - Costa Rica 6
ET - Etiopia 6
LY - Libia 6
NZ - Nuova Zelanda 6
PE - Perù 6
RS - Serbia 6
DZ - Algeria 5
JM - Giamaica 5
KG - Kirghizistan 5
NP - Nepal 5
RO - Romania 5
TW - Taiwan 5
LB - Libano 4
NG - Nigeria 4
PA - Panama 4
PT - Portogallo 4
AL - Albania 3
AO - Angola 3
BG - Bulgaria 3
GE - Georgia 3
HN - Honduras 3
HU - Ungheria 3
LK - Sri Lanka 3
PY - Paraguay 3
UY - Uruguay 3
YE - Yemen 3
BO - Bolivia 2
EE - Estonia 2
KW - Kuwait 2
MD - Moldavia 2
PS - Palestinian Territory 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BZ - Belize 1
CG - Congo 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DO - Repubblica Dominicana 1
Totale 15.970
Salva come PNG Salva come JPEG
Città #
Singapore 1.077
Ashburn 911
Warsaw 600
San Jose 577
Woodbridge 574
Beijing 488
Chandler 411
Fairfield 407
Jacksonville 381
Santa Clara 346
Hong Kong 333
Houston 317
Ann Arbor 296
Wilmington 183
New York 161
Ho Chi Minh City 150
Seattle 144
Ferrara 137
Nanjing 136
Los Angeles 127
Cambridge 121
Munich 117
Izmir 114
Dallas 109
Tokyo 109
Hanoi 106
Princeton 91
Lauterbourg 83
Council Bluffs 79
Bologna 72
Boardman 65
Shanghai 65
Jakarta 62
Addison 61
Milan 61
Bremen 55
Turku 52
Shenyang 42
São Paulo 42
Helsinki 41
Redwood City 41
San Diego 41
Hefei 40
Orem 40
Mexico City 39
Chennai 33
Rio de Janeiro 31
Brooklyn 29
London 28
Nanchang 26
Jiaxing 24
Montreal 24
Moscow 24
Tianjin 24
Toronto 24
Buffalo 23
Denver 23
Dearborn 22
Falkenstein 22
Jinan 22
Changsha 21
Chicago 21
Da Nang 21
Johannesburg 21
Haiphong 20
Hebei 20
San Francisco 20
Atlanta 19
Auburn Hills 19
Brussels 19
Frankfurt am Main 18
Ferrara di Monte Baldo 17
Stockholm 17
Belo Horizonte 16
Manchester 16
Tashkent 16
The Dalles 16
Dhaka 15
Falls Church 15
Poplar 15
Brasília 14
Dong Ket 14
Guangzhou 14
Mountain View 14
Mumbai 14
Phoenix 14
Rome 14
Boston 13
Curitiba 13
Leiden 13
Brno 12
Caracas 12
Norwalk 12
Zhengzhou 12
Ankara 11
Buenos Aires 11
Sydney 11
Baghdad 10
Ningbo 10
Amsterdam 9
Totale 10.492
Salva come PNG Salva come JPEG
Nome #
An Aγ-globin G->A gene polymorphism associated with β(0)39 thalassemia globin gene and high fetal hemoglobin production 416
A validated cellular biobank for β-thalassemia 415
BCL11A mRNA targeting by miR-210: A possible network regulating γ-globin gene expression 378
TREATMENT OF BETA-THALASSEMIA PATIENTS WITH RAPAMYCIN (SIROLIMUS): FROM PRE-CLINICAL RESERCH TO A CLINICAL TRIAL 353
A validated THALAMOSS cellular biobank for β-thalassemia 334
Generation and characterization of a transgenic mouse carrying a functional human β-globin gene with the IVSI-6 thalassemia mutation 298
The (A)gamma(+25 G -> A) polymorphism is associated with high HbF production leading to a decrease in binding activity of the LYAR transcription factor to the (A)gamma-globin gene in beta-thalassemia patients 293
A Novel Frameshift Mutation (+A) at Codon 18 of the beta-Globin Gene Associated with High Persistence of Fetal Hemoglobin Phenotype and deltabeta-Thalassemia 274
A combined approach for β-thalassemia based on gene therapy-mediated adult hemoglobin (HbA) production and fetal hemoglobin (HbF) induction 243
A Saccharomyces cerevisiae model suitable for screening of correctors of stop-codon mutations 230
Discovery of novel fetal hemoglobin inducers for β-thalassemia by small chemical library screening 229
Increase of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of rapamycin regulated proteins following mithramycin treatment of human erythroid cells 226
Bis-epoxyethyl derivatives of distamycin A modified on the amidino moiety: Induction of production of fetal hemoglobin in human erythroid precursor cells 222
Development of K562 cell clones expressing beta-globin mRNA carrying the beta039 thalassemia mutation for the screening of correctors of stop codon mutations 214
Combining gene therapy with fetal hemoglobin induction on erythroid precursor cells from β039 and IVS-I-110 thalassemia patients 213
Structure and Biological Activity of Furocoumarins 205
The multicenter THALAMOSS cellular Biobank for β-Thalassemia 204
Combining gene therapy and fetal hemoglobin induction for treatment of β-thalassemia 193
Generation and molecular characterization of a transgenic mouse line carrying a mutated human IVS-I-6 thalassemia beta-globin gene 189
Surface plasmon resonance based analysis of the binding of LYAR protein to the rs368698783 (G>A) polymorphic Aγ-globin gene sequences mutated in β-thalassemia 188
Expression of γ-globin genes in β-thalassemia patients treated with sirolimus: results from a pilot clinical trial (Sirthalaclin) 187
Cellular biosensors for the identification of fetal hemoglobin inducers 186
Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of γ-globin and β-globin gene promoters 186
Production of β-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous β039 thalassemia patients 185
Double effects of mithramycin during induction of fetal hemoglobin: down regulation of BCL11A gene transcription and inhibition of the binding of the BCL11A transcriptional complex to the -globin gene promoter 185
Bergamot (Citrus bergamia Risso) fruit extracts as gamma-globin gene expression inducers: Phyto-chemical and functional perspectives 183
Structural and Functional Insights on an Uncharacterized Aγ-Globin-Gene Polymorphism Present in Four β(0)-Thalassemia Families with High Fetal Hemoglobin Levels 182
Development and molecular characterization of transgenic mice for beta-thalassemia 175
Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of gamma-globin and beta-globin gene promoters 175
PNAs targeting BCL11A at the miR-210 binding sites down-regulate BCL11A and up-regulate gamma-globin mRNA 173
Differentiation and apoptosis in UVA-irradiated cells treated with furocoumarin derivatives 170
New synthetic isoxazole derivatives as potent inducer of fetal hemoglobin (HbF) in beta-thalassemia 168
Erythroid Induction of Chronic Myelogenous Leukemia K562 Cells Following Treatment with a Photoproduct Derived from the UV-A Irradiation of 5-Methoxypsoralen 167
Encapsulation of mithramycin into polymeric micelles by microfluidics: Regulation of the expression of the human γ-globin genes 166
Induction of erythroid differentiation and increased globin mRNA production with furocoumarins and their photoproducts 166
Erythroid differentiation ability of butyric acid analogues: Identification of basal chemical structures of new inducers of foetal haemoglobin 166
A Rational Approach to Drug Repositioning in β-thalassemia: Induction of Fetal Hemoglobin by Established Drugs 165
Effects on erythroid differentiation of platinum(II) complexes of synthetic bile acid derivatives 164
Effects of Tobramycin activity on premature termination codons and interleukin 8 gene expression 162
Gene therapy combined with HbF induction in beta-thalassemia 161
Involvement of miRNA in erythroid differentiation 157
Gene therapy and fetal hemoglobin induction 155
Effects of Sirolimus treatment on patients with β-Thalassemia: Lymphocyte immunophenotype and biological activity of memory CD4+ and CD8+ T cells 152
Targeting the miR-221/miR-222 cluster in cancer therapy 152
Resveratrol: Antioxidant activity and induction of fetal hemoglobin in erythroid cells from normal donors and β-thalassemia patients 148
Evidences for miRNA regulation of BCL11A gene expression 146
Preparation and biological evaluation of some 1,2-O-isopropylidene-D-hexofuranose esters 144
Recent trends in the gene therapy of β-thalassemia 143
Transcription factors (TFs) negatively regulating gamma-globin gene transcription: BCL11A is down-regulated during mithramycin induction of erythroid cells from beta-thalassemia patients 141
Sirolimus-mediated induction of fetal hemoglobin in beta-thalassemia: impact of the XmnI rs74482144 polymophism 140
Production and molecular characterization of transgenic mice models for screening therapeutic agents for beta-thalassemia 136
Down-regulation of LYAR is associated with induction of fetal hemoglobin in mithramycin-treated erythroid cells 135
Synthesis and cellular pharmacology studies of a series of 2-amino-3-aroyl-4-substituted thiophene derivatives 134
Co-Treatment of Erythroid Cells from β-Thalassemia Patients with CRISPR-Cas9-Based β039-Globin Gene Editing and Induction of Fetal Hemoglobin 133
Effects of Sirolimus Treatment on Fetal Hemoglobin Production and Response to SARS-CoV-2 Vaccination: A Case Report Study 133
A β-Thalassemia Cell Biobank: Updates, Further Validation in Genetic and Therapeutic Research and Opportunities During (and After) the COVID-19 Pandemic 132
Decrease in α-Globin and Increase in the Autophagy-Activating Kinase ULK1 mRNA in Erythroid Precursors from β-Thalassemia Patients Treated with Sirolimus 129
Effects of rapamycin on accumulation of alpha-, beta- and gamma-globin mRNAs in erythroid precursor cells from beta-thalassaemia patients 129
Hemoglobin production in beta-thalassemia erythroid cells following alteration of biomolecular pathways regulating globin gene expression 129
Efficient CRISPR-Cas9-based genome editing of β-globin gene on erythroid cells from homozygous β039-thalassemia patients 129
Everolimus is a potent inducer of erythroid differentation and gamma-globin gene expression in human erythroid cells 128
Induction of erythroid differentiation and increased globin mRNA production with furocoumarins and their photoproducts. 128
Increase in gamma-globin mRNA content in human erythroid cells treated with angelicin analogs 127
Increase of the expression of gamma-globin gene in human erytroid cells treated with psoralens 126
Production of s-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous s039 thalassemia patients 126
Inhibitory effects of SARS-CoV-2 spike protein and BNT162b2 vaccine on erythropoietin-induced globin gene expression in erythroid precursor cells from patients with β-thalassemia 125
Therapeutic molecules for the development of a read-through approach for diseases caused by nonsense mutations 123
Development of a transgenic mouse line carrying a functional human Beta-globin gene with the IVSI-6 thalassemia mutation for in vivo screening and validation of aberrant splicing correctors 120
Increased Expression of α-Hemoglobin Stabilizing Protein (AHSP) mRNA in Erythroid Precursor Cells Isolated from β-Thalassemia Patients Treated with Sirolimus (Rapamycin) 119
Generation and molecular characterization of a transgenic mouse line carrying a mutated human β°39 thalassemia β-globin gene 118
Mithramycin-mediated induction of K562 cell erythroid differentiation is associated with inhibition of the mTOR-CI patway 117
Human bladder carcinoma cell line 5637 encapsulated in alginate microbeads: release of interleukins, chemokines and growth factors. 116
Production of a cellular model for the screening of inducers of fetal haemoglobin 114
Effects of Mithramycin on BCL11A Gene Expression and on the Interaction of the BCL11A Transcriptional Complex to γ-Globin Gene Promoter Sequences 111
Mithramycin-mediated regulation of raptor gene transcription during erythroid differentiation of K562 cells 111
Thalassemia mouse model for beta-globin gene IVSI-6 mutation 110
Sex-specific transcriptional profiles identified in β-thalassemia patients 110
Expression of miR-210 during erythroid differentiation and induction of gamma-globin gene expression 108
Readthrough of the premature stop codon beta039-thalassemia 107
null 107
New Synthetic Isoxazole Derivatives Acting as Potent Inducers of Fetal Hemoglobin in Erythroid Precursor Cells Isolated from β-Thalassemic Patients 104
Orphan Drugs and Potential Novel Approaches for Therapies of β-Thalassemia: Current Status and Future Expectations 104
Increase of accumulationof gamma-globin mRNA in human erythroid cells treated with psoralens 103
null 103
Treatment of erythroid precursor cells from β‐thalassemia patients with cinchona alkaloids: Induction of fetal hemoglobin production 102
Teaching during COVID-19 pandemic in practical laboratory classes of applied biochemistry and pharmacology: A validated fast and simple protocol for detection of SARS-CoV-2 Spike sequences 99
The Long Scientific Journey of Sirolimus (Rapamycin): From the Soil of Easter Island (Rapa Nui) to Applied Research and Clinical Trials on β-Thalassemia and Other Hemoglobinopathies 97
Novel biological activity of psoralens. Induction of accumulation of g-globin mRNA in human erythroid cells 97
Induction of accumulation of gamma-globin mRNA in human erythroid cells treated with psoralens 96
Erythroid differentiation induced by mithramycin in K562 cells is associated with inhibition of the mTOR-C1 pathway 95
Induction of accumulation of gamma-globin mRNA in human erythroid cells treated with psoralens 92
Production and Characterization of K562 Cellular Clones Hyper-Expressing the Gene Encoding α-Globin: Preliminary Analysis of Biomarkers Associated with Autophagy 91
THALAssaemia MOdular Stratification System for personalized therapy of beta-thalassemia 91
The rs368698783 (G>A) Polymorphism Affecting LYAR Binding to the Aγ-Globin Gene Is Associated with High Fetal Hemoglobin (HbF) in β-Thalassemia Erythroid Precursor Cells Treated with HbF Inducers 89
null 87
null 85
Ultra sensitive plasmonic devices for early cancer diagnosis 84
null 75
Tobramycin is a suppressor of premature termination codons. 74
Expression of miR-210 during erythroid differentiation and induction of gamma-globin gene expression 71
Totale 15.776
Salva come PNG Salva come JPEG
Categoria #
all - tutte 70.258
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 682
Totale 70.940
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021118 0 0 0 0 0 0 0 0 0 0 0 118
2021/2022852 87 77 37 25 50 42 46 37 23 80 85 263
2022/2023958 95 91 23 125 174 129 72 82 81 8 42 36
2023/2024673 34 103 27 17 82 124 78 45 10 8 16 129
2024/20252.395 74 57 201 141 270 189 73 104 387 308 317 274
2025/20266.207 634 285 483 758 900 392 765 372 647 697 256 18
Totale 16.243